One of the key highlights of our corporate partnership scheme is the opportunity to exhibit at the CMHP Annual Conference in October.
If you are interested in exhibiting at our 2025 conference, you can find out about our exhibitors and corporate partner packages here:
2025 corporate partners
Katalyst Diagnostics offers best in class cutting-edge diagnostic solutions and is helping mental health trusts revolutionise clozapine monitoring through their innovative Point of Care testing analysers. Our portable, plug & play analysers now offer finger-prick as well as venous sample testing for both Full Blood Count (FBC) and Clozapine-levels from just one drop of blood. The HemoScreen FBC analyser offers results within 5 minutes whereas Saladax MyCare Insite, provides the clozapine level results in less than 7 minutes. This approach minimizes patient discomfort and reduces the time and complexity associated with traditional venepuncture methods. Katalyst Diagnostics' technology not only enhances patient compliance but also empowers mental health trusts with rapid and accurate insights, ultimately advancing the effectiveness and efficiency of clozapine treatment.
In Europe, Teva Pharmaceuticals is located across all major markets, operating across 28 manufacturing sites and employing over 19,000 people across its operations and commercial activities. We’re the leading generic drug company and our legacy in high-quality generics enables us to leverage our capabilities to bring forward complex generics and biosimilars at scale, to help create more value for patients and healthcare systems. We also have a strong innovative medicines portfolio focused on central nervous system disorders, respiratory diseases, and oncology.
Through a global network of capabilities, we are discovering, developing, and delivering our innovative, generic, and biosimilar medicines to unlock more possibilities for patient care, and positioning our business for greater opportunity and greater impact.
Teva in the UK: dedicated to improving the lives of patients